Release Date: October 31, 2025
Expiration Date: October 31, 2026
Activity Overview
This online, on-demand virtual symposium brings together renowned experts in neuromuscular disease, with a focus on generalized myasthenia gravis (gMG). In this educational program, these experts discuss the groundbreaking therapies now available that target the underlying autoimmune mechanisms more precisely than traditional treatments. These targeted therapies represent a shift from broad immunosuppression to more precise interventions, offering patients better symptom control with potentially fewer adverse effects compared to traditional corticosteroids and immunosuppressants.
This educational activity is an archive of the live symposium held on September 27, 2025.
Target Audience
This educational activity is directed toward neuromuscular disease specialists, neurologists, specialty nurse practitioners, specialty physician assistants, nurses, and other health care providers involved in the care of patients with neuromuscular diseases.
Learning Objectives
Upon successful completion of this activity, you should be better prepared to:
- Identify the pathophysiological pathways underlying generalized myasthenia gravis
- Evaluate emerging data on targeted therapies for gMG
- Integrate targeted therapies into individualized management plans for patients with gMG
GET STARTED WITH THIS PROGRAM:
Register now to gain access to this program.
Create AccountAlready Registered? Login Here